Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences P. MacherasP. ArgyrakisC. Polymilis OriginalPaper Pages: 77 - 86
Controlled release dosage forms: from ground to space P. ColomboR. BettiniP. Santi OriginalPaper Pages: 87 - 91
The relevance of pharmacokinetics in the development of biotechnology products S. Toon OriginalPaper Pages: 93 - 103
Sparse sampling for assessment of drug exposure in toxicological studies P. BurtinF. MentreJ. L. Steimer OriginalPaper Pages: 105 - 111
Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response M. Jerling OriginalPaper Pages: 113 - 121
Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype A. LlerenaJ. CobaledaJ. Benítez OriginalPaper Pages: 129 - 138
From sticky stuff to sweet receptors — achievements, limits and novel approaches to bioadhesion C. M. Lehr OriginalPaper Pages: 139 - 148
Bioequivalence assessment and the conduct of bioequivalence trials: a European point of view A. Herchuelz OriginalPaper Pages: 149 - 152
Bioequivalence assessment: a pharmaceutical industry perspective J. GodbillonJ. M. CardotA. Sioufi OriginalPaper Pages: 153 - 158
Bioequivalence assessment of generic drugs: an American point of view R. PatnaikL. J. LeskoR. L. Williams OriginalPaper Pages: 159 - 164
Pharmacoeconomics: where is the link with pharmacokinetics and biopharmaceutics? F. Peys OriginalPaper Pages: 189 - 200